VENN STRATEGIES

Lobbying for ELI LILLY AND COMPANY · Pharmaceutical company

Filing 3rd Quarter - Report

3rd Quarter (July 1 - Sep 30) 2025 · District of Columbia · House · Senate · $50,000.00 income · posted Oct 20, 2025

Lobbying activity 1

Health Issues

General Healthcare issues, including drug accessibility, importation and innovation policies.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.